This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bcn Peptides S.a.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Laura Gort Mas: Innovator in Lysosomal Storage Disorder Treatments
Introduction
Laura Gort Mas is a prominent inventor based in Balenyà, Spain. She has made significant contributions to the field of medical research, particularly in the treatment of lysosomal storage disorders. Her innovative work focuses on developing therapies that can alleviate the symptoms of these complex diseases.
Latest Patents
Laura Gort Mas holds a patent for "Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis." This invention provides a novel therapy for lysosomal storage diseases and glycogenosis by utilizing compounds that promote exocytosis, specifically lysosomal exocytosis. The treatment has shown promise in reducing the accumulation of toxic substrates in lysosomes, thereby offering a potential solution for the treatment, prevention, and relief of symptoms associated with various lysosomal storage disorders.
Career Highlights
Throughout her career, Laura has demonstrated a strong commitment to advancing medical science. Her work has not only contributed to the understanding of lysosomal storage disorders but has also paved the way for new therapeutic approaches. She is affiliated with Bcn Peptides S.A., where she continues to innovate and collaborate with other experts in the field.
Collaborations
Laura Gort Mas has worked alongside notable colleagues such as Josep Farrera-Sinfreu and Leslie Matalonga Borrel. These collaborations have enhanced her research and contributed to the development of effective treatments for lysosomal storage disorders.
Conclusion
Laura Gort Mas is a trailblazer in the field of medical innovation, particularly in the treatment of lysosomal storage disorders. Her groundbreaking patent and collaborative efforts highlight her dedication to improving patient outcomes through scientific advancement.